.GAMMA.-BRAIN NATRIURETIC PEPTIDE

Hyperinsulinemia

protein_peptideEarly Phase 1Dormant

C

38/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 24/ 100
Competitive Position: 81/ 100

Competitive context

19 Active assets in the Hyperinsulinemia cohort.

Asset / Sponsor	Phase	Rating
Metformin Attikon Hospital	Phase 4	BB
Metformin Attikon Hospital	Phase 4	BB
EUDEMINE INJECTION Columbia University	Phase 2	B
Insulin-Like Growth Factor I Children's Hospital of Philadelphia	Phase 2	B
Rosiglitazone New York Medical College	Phase 2	B

View all 25 →

Same molecule, other indications

.GAMMA.-BRAIN NATRIURETIC PEPTIDE is also rated in:

diabetes mellitusDormant

CCC

Indicative ·

48 / 100

cardiovascular disorderDormant

CC

Indicative ·

46 / 100

obesity disorderDormant

CC

Indicative ·

44 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.